Clinical Trial Update: A Study of YL202 in Patients With Advanced Solid Tumors [Phase 2]

View source ↗

Summary

A Phase 2 trial of YL202 in patients with advanced solid tumors is currently recruiting, including non-small cell lung cancer, colorectal cancer, and cervical c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Colorectal Cancer
• Non-small Cell Lung Cancer
• Or Metastatic Solid Tumors

Drugs mentioned

• YL202

Snippet

Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. | Conditions: Non Small Cell Lung Cancer, Colorectal Cancer | Phase 2 | Status: RECRUITING